Our major strength is that this is the largest multicentre study investigating the diagnostic value of NfL and GFAP in a well-characterised retrospective study cohort (DIPPA-FTD) including only sporadic bvFTD and late-onset PPD. The gene discussed is NEFL; the disease is progressive pseudorheumatoid arthropathy of childhood.